Impact of concomitant medication use and immune-related adverse events on response to immune checkpoint inhibitors

AIM: Patients receiving checkpoint inhibitors (CPI) are frequently on other medications for co-morbidities. We explored the impact of concomitant medication use on outcomes. MATERIALS & METHODS: 210 metastatic cancer patients on CPI were identified and association between concomitant medication...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Immunotherapy
Main Authors: Gandhi, Shipra, Pandey, Manu, Ammannagari, Nischala, Wang, Chong, Bucsek, Mark J, Hamad, Lamya, Repasky, Elizabeth, Ernstoff, Marc S
Format: Artigo
Jezik:Inglês
Izdano: Future Medicine Ltd 2020
Teme:
Short Communication
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7202260/
https://ncbi.nlm.nih.gov/pubmed/32064978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2019-0064
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki